These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11496864)

  • 21. Fluvoxamine treatment of mixed anxiety and depression: evidence for serotonergically mediated anxiolysis.
    Rausch JL; Hobby HM; Shendarkar N; Johnson ME; Li J
    J Clin Psychopharmacol; 2001 Apr; 21(2):139-42. PubMed ID: 11270909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal Side Effects in the Baby of a Breastfeeding Woman Treated with Low-Dose Fluvoxamine.
    Uguz F
    J Hum Lact; 2015 Aug; 31(3):371-3. PubMed ID: 25896469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased libido in a woman treated with fluvoxamine: a case report.
    Hori H; Yoshimura R; Nakamura J
    Acta Psychiatr Scand; 2001 Apr; 103(4):312-4. PubMed ID: 11328247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression and anxiety: pharmacological treatment in general practice.
    Ellen S; Selzer R; Norman T; Blashki G
    Aust Fam Physician; 2007 Apr; 36(4):222-8. PubMed ID: 17392933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination.
    Pratheesh PJ; Praharaj SK; Srivastava A
    Psychopharmacol Bull; 2011; 44(1):70-3. PubMed ID: 22506441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity with selective serotonin reuptake inhibitors.
    Solomons K; Gooch S; Wong A
    Am J Psychiatry; 2005 Jun; 162(6):1225. PubMed ID: 15930079
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluvoxamine and mandibular dystonia.
    Chong SA
    Can J Psychiatry; 1995 Sep; 40(7):430-1. PubMed ID: 8548729
    [No Abstract]   [Full Text] [Related]  

  • 28. Photosensitivity reaction associated with selective serotonin re-uptake inhibitors: possible cross-sensitivity?
    Cheng YC; Huang MC
    Psychiatry Clin Neurosci; 2014 Mar; 68(3):244. PubMed ID: 24895743
    [No Abstract]   [Full Text] [Related]  

  • 29. Optimizing Clozapine Benefit While Minimizing Adverse Effects with Concomitant Fluvoxamine Treatment in an Adolescent with Schizoaffective Disorder.
    Rice T; Friedman S; Tatum J; Weiss-Goldman N; Kufert Y; Coffey BJ
    J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):66-71. PubMed ID: 30681385
    [No Abstract]   [Full Text] [Related]  

  • 30. Improved outcome in fluvoxamine-treated patients with SSRI-induced sexual dysfunction.
    Banov MD
    J Clin Psychiatry; 1999 Dec; 60(12):866-8. PubMed ID: 10665636
    [No Abstract]   [Full Text] [Related]  

  • 31. Psychopharmacologic treatment of children and adolescents with anxiety disorders.
    Strawn JR; Sakolsky DJ; Rynn MA
    Child Adolesc Psychiatr Clin N Am; 2012 Jul; 21(3):527-39. PubMed ID: 22800992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Documented effects of SSRI preparations in anxiety].
    Allgulander C
    Lakartidningen; 1998 May; 95(21):2464-7. PubMed ID: 9640919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy for anxiety disorders in children and adolescents.
    Kodish I; Rockhill C; Varley C
    Dialogues Clin Neurosci; 2011; 13(4):439-52. PubMed ID: 22275849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ondansetron-Induced Myoclonus With Escitalopram and HAART: Role of Drug Interactions.
    Kolli V; Addula M
    Prim Care Companion CNS Disord; 2019 Jul; 21(4):. PubMed ID: 31364825
    [No Abstract]   [Full Text] [Related]  

  • 35. Deliberate self-poisoning following fluvoxamine-neuroleptics combination.
    Chong SA; Cheong A
    J Clin Psychiatry; 1999 Dec; 60(12):869. PubMed ID: 10665638
    [No Abstract]   [Full Text] [Related]  

  • 36. Sexual dysfunction and fluvoxamine therapy.
    Waldinger MD; Olivier B
    J Clin Psychiatry; 2001 Feb; 62(2):126-7. PubMed ID: 11247099
    [No Abstract]   [Full Text] [Related]  

  • 37. Disinhibition as a side effect of treatment with fluvoxamine in pediatric patients with obsessive-compulsive disorder.
    Harris E; Eng HY; Kowatch R; Delgado SV; Saldaña SN
    J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):347-53. PubMed ID: 20807074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case of rapid bilateral cataract development in teenager using selective serotonin reuptake inhibitors.
    Kisilevsky E; Margolin EA
    Can J Ophthalmol; 2014 Oct; 49(5):e114-5. PubMed ID: 25284112
    [No Abstract]   [Full Text] [Related]  

  • 39. A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder.
    van Vliet IM; den Boer JA; Westenberg HG; Slaap BR
    J Clin Psychopharmacol; 1996 Aug; 16(4):299-306. PubMed ID: 8835705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of safety in pediatric psychopharmacology.
    Greenhill LL
    J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):625-6. PubMed ID: 12921468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.